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Abstract
Background: Morbid obesity has become one of the most frequent chronic medical disorders in Western countries,
affecting 1.5-2 % of the Dutch population. Currently, the laparoscopic Roux-Y gastric bypass is considered to be the most
effective bariatric treatment option for morbid obesity as it results in adequate weight loss and a significant decrease in
comorbidity. Although this technique has been applied for years, the optimal lengths of the three bowel limbs (alimentary
limb, biliopancreatic limb, and common channel) in order to achieve maximal percentage excess weight loss with
minimal side effects (i.e. malabsorption symptoms), are unknown. As ‘normal’ sized gastric bypasses achieve an average
of 60 − 80 % excess weight loss after one year, one could hypothesize that afferent limb lengths should be longer in order
to reduce the common channel length, thereby improving outcome in terms of excess weight loss.
The aim of the current study is to investigate the effect of the length of the common channel in gastric bypass surgery for
morbid obesity. In this randomized controlled trial the very long Roux limb gastric bypass will be compared to the standard
gastric bypass, in order to conclude which option is the optimal therapeutic strategy in the morbidly obese patient.
Methods/design: In this multicentre trial patients will be randomized either to a very long Roux limb gastric bypass with a
fixed common channel length of 100 cm, or to a standard gastric bypass with a variable common channel length.
The primary objective is to evaluate whether the very long Roux limb gastric bypass is superior in terms of percentage
excess weight loss after one year follow-up compared to the standard gastric bypass.
Secondary endpoints are quality-of-life, cure /improvement of obesity related comorbidity, complications, malnutrition,
re-admission rate, and re-operation rate.
Discussion: We hypothesize that our proposed distal LRYGB will provide for improved results concerning % EWL with an
acceptable rate of (metabolic) complications.
Our main point of interest is to determine if the distal LRYGB is a superior alternative to standard LRYGB in terms of
percentage excess weight loss and to put more focus on the role of the common channel. Therefore we will perform this
randomized controlled trial comparing both techniques, with % EWL as a primary outcome.
Trial registration: CCMO registration number: NL43951.101.13 and Netherlands Trial Registry number: NTR4466.
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Background
Obesity is a global problem in Western societies. The
World Health Organization (WHO) states that currently
obesity is the most serious chronic health problem world-
wide [1]. In some western industrial countries over 50 %
of the population is overweight. The mortality risk is dou-
bled for women with BMI of >40 kg/m2 and tripled for
men. Moreover, the earlier obesity occurs with regard to
age, the stronger the rise in mortality risk [2].
Treating morbid obesity (defined as a BMI > 40 kg/m2)
by non-surgical methods has only resulted in minor ef-
fects. Surgical treatment has gained widespread accept-
ance in recent decades due to its superior outcomes in
weight loss [3–5]. In 1992 the WHO stated that bariatric
surgery is the only effective treatment to achieve long
lasting weight loss [1]. Furthermore, bariatric surgery
has profound effects on obesity-related co-morbidities,
such as type 2 diabetes mellitus, hypertension and sleep
apnea, [6]. Bariatric surgery is also safer than conserva-
tive treatment for obesity in terms of a lower lifelong
mortality risk caused by morbid obesity [7].
Surgical interventions for morbid obesity can be di-
vided into two categories: interventions that cause food
malabsorption and interventions that cause food restric-
tion. Laparoscopic Roux-en-Y gastric bypass (LRYGB)
has been acknowledged to be safe and effective for the
treatment of morbid obesity, and is globally considered
the golden standard surgical technique [1, 7–9].
After one year follow-up, LRYGB results in an average
of 60–80 % excess weight loss (% EWL) with reduction
in comorbidities. However, a partial weight regain can be
seen during long-term follow-up [10].
Consensus does exist on the need for a small calibrated
gastric pouch in the LRYGB in order to achieve improved
% EWL results. However, to date little attention has been
given to determine the optimal lengths of the various intes-
tinal limbs that comprise the operation (the alimentary or
‘Roux’ limb and the biliopancreatic limb or afferent limb)
(see Fig. 1). These limb-lengths are important as they deter-
mine the amount of weight loss and the incidence of adverse
events related to malnutrition and malabsorption.
No consensus has been reached on the optimal lengths
of the limbs. In an internet-based study performed by
Madan et al. on preferred technique of 215 bariatric sur-
geons, all of whom are members of the American Society
for Metabolic and Bariatric Surgery, showed a wide range
of the AL and BL limbs lengths (average 110 [range
35–250]cm for AL, and 48 [range 10–250]cm for BL) [11].
The common channel (where the food arriving through
the alimentary limb (AL) is mixed with gastric, bilary, and
pancreatic fluids coming from the biliopancreatic limb (BL)
(Fig. 1), absorbs most of the nutrients and preserves entero-
hepatic circulation of bile salts and fat [12]. Some absorption
of amino acids and glucose may occur in the AL as well,
through the saliva and succus which may digest proteins
and carbohydrates. In the BL, as the digestive fluids pass
through its mucosa, reabsorption of digestive components
such as lipases may also occur, which decrease the digestive
potential of the fluid reaching the food in the common
channel [12].
In the specific population of super-obese patients it has
been suggested that an increase in malabsorbtion may be
established by creating a longer AL, resulting in an increase
in weight loss in this selected group of patients [13, 14].
A review of the available literature on different limb
lengths in LRYGB identified four randomized controlled
trials (RCT).
It has been concluded that the currently available litera-
ture supports the notion that a longer AL (at least 150 cm)
may be associated with a modest weight loss in the short-
term for superobese patients, but without a significant im-
pact on patients with BMI < 50 [13, 14]. Limitations of the
available literature include the heterogeneity of studies, small
study populations, and lack of standardization. Furthermore,
the length of the common channel was not accounted for in
these studies.
Nevertheless, there is evidence that the degree of mal-
absorption after gastric bypass is influenced mainly by
the length of the common channel [15]. Therefore it has
been suggested that good quality studies that focus on
the impact of the length of the common channel on
weight loss are urgently needed [14].
When searching for the optimal lengths of the bypass
limbs, it is known that one cannot lengthen the
alimentary limb without facing metabolic complications.
Complications associated with biliopancreatic diversion
and very long-limb RYGB are mostly due to a too short
common channel [16]. Kalfarentzos et al. [17] found
that 100 cm common channel in biliopancreatic
diversion with RYGB and long limbs is a safe length for
achieving satisfactory % EWL without major nutritional
deficiencies.
In 2006 Nelson et al. [18] described a “very, very long
limb” Roux-en-Y gastric bypass in a series of super
obese patients in which a 100 cm CC was created, with
a 60 cm BL and a “very, very” long Roux or AL of 400 to
500 cm. In this study 82 % of patients lost >50 % of
excess body weight. Nine (4 %) patients required
re-operation due to protein/calorie malnutrition in this
group by proximal relocation of the enteroenterostomy
with symptom resolution in all patients.
Recently Thurnheer et al. [19] published on a so called
distal very long RYGB with an average CC of 76 cm
(±7 cm), BL of 79 cm (±14 cm) and variable AL lengths
of 604 cm (±99 cm). Average EWL in this population of
355 patients was >74 % up to 5 years after the operation
and failure rate was relatively low (<6 %). The incidence
of severe malnutrition states was relatively low (1.7 %)
Gadiot et al. BMC Obesity  (2015) 2:28 Page 2 of 7
and the complication rate (4.5 % major and 10.4 %
minor complications) was comparable to the literature.
We hypothesized that distal LRYGB as stated in the
present proposal will have similar results in terms of
% EWL as the distal very long RYGB described by
Thurnheer on the % EWL after 1 year (69.7 %; SD 18.3),
this will be used to calculate group sizes for this study.
The proposed technique was first described by the
group of Sarr [20] and termed very, very long limb
Roux-en-Y gastric bypass (VVLL-RYGB). We feel that
very long Roux limb gastric bypass (VLRL-RYGB)
describes the proposed technique more clearly and will
therefore be used in this article.
Data required for the calculation of group sizes was
not reliable and therefore the data from the study by
Thurnheer [19] will be used for this purpose.
In conclusion, currently there is no consensus about
the optimal length of the alimentary, biliopancreatic
limb and common channel for achieving best weight
loss results, and more studies are needed to determine
the role of the common channel in LRYGB.
We hypothesize that VLRL-RYGB (with standardised
common channel length of 100 cm) will result in a
better weight loss result, in terms of % EWL after one
year when compared to standard LRYGB.
Methods
Study objective
To determine if the very long Roux limb gastric bypass
is superior to standard gastric bypass as a surgical treat-
ment for morbid obesity in terms of percentage excess
weight loss after one year.
Study design
The DUCATI-trial is a multi centre, randomized
controlled, trial. The study compares very long Roux
limb gastric bypass and standard laparoscopic Roux - Y
gastric bypass. Patients will be randomly allocated to
A) VLRL-RYGB or B) standard LRYGB and will be
followed for a period of at least 1 year. The study will be
performed in a clinical and outpatient setting with
regular visits at 2, 6, and 12 months post intervention.
Randomisation is stratified for the participating
centres. Randomisation takes place in the operation
room and is single blinded.
Fig. 1 Schematic overview of the limbs of the LRYGB
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Patient selection
Study subjects are selected from a clinical population
of the Sint Franciscus Gasthuis, Rotterdam, The
Netherlands and the Lievensberg hospital, Bergen op
Zoom, The Netherlands. All morbidly obese patients
who have had no prior bariatric surgery and who are eli-
gible for primary laparoscopic gastric bypass surgery are
candidates for the trial.
Inclusion criteria are:
– Age 18–60 years
– BMI > 40, or >35 kg/m2 with obesity related co-
morbidity
– Psychological screening excluding psychiatric and
psychological disorders
– Informed consent and willing to enter the follow up
program after the operation.
Exclusion criteria are:
– Prior bariatric surgery
– Prior major abdominal surgery (like colonic resection,
septic abdomen, aorta surgery, or other procedures with
a high risk of intra-abdominal adhesions, which might
jeopardise the possibility of performing aVLRL-RYGB,
standard LRYGB
– ASA (American Society for Anesthesiologists)
classification ≥ IV
– Pregnant women
– Endocrine causes, alcohol or drug abuse
– Severe concomitant disease (carcinomas,
neurodegenerative disorders or other disorders
presently representing being considered exclusion
criteria for bariatric surgery )
– The inability of reading/understanding and filling
out questionnaires
– VLRL-RYGB or LYRGB is technically not possible
as will be determined by the surgeon during surgery.
Study questions and outcome measures
Primary endpoint: Is the VLRL-RYGB superior to stand-
ard LRYGB in terms of percentage excess weight loss
after one year?
Excess weight (kg) will be calculated with the formula
EW=AW-IW (actual weight- ideal weight), IW= 22 × L2
(L = length in meters). The amount of weight loss will be
expressed as percentage excess weight loss (%EWL), and
calculated with the formula % EWL= (pre-operative BMI –
current BMI) / (pre-operative BMI-25) × 100 %.
Secondary endpoint: what is the effect of the interventions
on quality-of-life (QOL), cure /improvement of obesity re-
lated co-morbidity, complications, malnutrition side effects,
re-admission rate, and re-operation rate?
The following outcome measures will be analysed to
answer these secondary questions:
Patient’s health-related quality of life (QoL) objectified
by the MOS Short Form 36 (SF 36), Gastro-Intestinal
Quality of Life Index, and Obesity related Quality of life
the Moorehead-Ardelt II questionnaires and the Bariatric
Analysis and Reporting Outcome System (BAROS) score.
DM-II, hypertension, hypercholesterolemia, GERD,
OSAS and joint-pain will be scored as worsened, same,
improved or cured at follow-up visits.
Operating time, mean hospital stay, intra-operative
and post-operative morbidity, and in-hospital mortality.
Morbidity is defined as reoperations, reinterventions, re-
admissions and serious adverse events. Morbidity is clas-
sified as major (anastomotic leakage, major peroperative
blood loss due to splenic or vascular hemorrhage,
pulmonary embolism, intra-abdominal abscess and
intra-abdominal hematoma) or minor (wound infection,
urinary tract infection and anastomotic stenosis) compli-
cations. For analysis the Clavien-Dindo classification will
be used [21]. Moreover, the rate of extra outpatient and
ER visits due to complaints are recorded.
Biochemical and hormonal values following VLRL-
RYGB and standard LRYGB will be evaluated by labora-
tory testing of the following parameters: Vitamin B1, B6,
B12, D, folic acid, HbA1C, ferritin, iron, transferrin,
cholesterol, HDL-cholesterol, LDL-cholesterol, triglycer-
ide, calcium, magnesium, albumin, Apo-B, Zinc, homo-
cysteine, parathomone.
Surgical interventions
After reviewing the literature we hypothesized that a stan-
dardized common channel length of 100 cm should be safe
to reduce major nutritional deficiencies, while remaining a
long alimentary limb. To ensure a degree of comparability
between VLRL-RYGB and standard LRYGB, the BL was set
at a fixed length of 60 cm.
Two different approaches for anastomosis are known, be-
ing the linear and the circular gastro-enterostomy stapling
techniques, which are both allowed in this study, as it does
not seem to affect the primary outcome measure; the per-
centage excess weight loss result (% EWL) [22]. The only
prerequisite is that the diameter of the gastro-enterostomy
anastomosis will be comparable. As the applied circular
stapler anastomosis is 25 mm, the linear stapled anasto-
mosis will need to be 25 mm in diameter as well. The type
of technique linear or circular will be registered.
Very long Roux limb gastric bypass
Technique (linear gastro-enterostomy stapling technique):
Approximately 6 cm below the angle of His a
calibrated gastric pouch is created using a 34 Fr gastric
tube. After creation of the pouch the omentum may be
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split vertically to ensure safe mobilization of the small
intestine if necessary.
The common channel is measured 100 cm from the
ileocoecal junction and marked with a temporary suture.
Next, the gastro-enterostomy is created 60 cm from
the point of Treitz, followed by creation of the entero-
enterostomy between the small intestine proximal from
the gastro-enterostomy and the marked point 100 cm
proximal to the ileocoecal junction.
After final stapling between the gastro-enterostomy and
the entero-enterostomy the alimentary limb is measured
using a set 5 cm marking on a babcock clamp.
Standard laparoscopic Roux-en-Y gastric bypass
Technique (linear gastro-enterostomy stapling technique):
Most steps are the same as mentioned for VLRL-RYGB.
The only difference is the lengths described in the steps of
creating the entero-enterostomy and measuring common
channel instead of the alimentary limb.
After creation of the gastro-enterostomy, 60 cm from
the point of Treitz, 150 cm is measured distal from the
gastro-enterostomy and an entero-enterostomy is created
between this point and the small intestine just proximal
from the gastro-enterostomy.
After final stapling between the gastro-enterostomy and
the entero-enterostomy the common channel is measured
using a set 5 cm marking on a babcock clamp.
Technique (circular gastro-enterostomy stapling
technique):
Most steps of this procedure are similar to the linear
stapling technique. The technique differs in the creation
of the gastro-enterostomy and the creation of the entero-
enterostomy. Furthermore, in the circular technique the
entero-enterostomy is created first.
In both groups and techniques the following is
applicable:
Petersen’s space and other internal hernias can be
closed by laparoscopic suturing or tackers and an ab-
dominal silicone drain may be left behind at the sur-
geons’ preference. Staple line bleeding is controlled by
electronic scissors, clips, or sutures. Next, the trocars
are removed under sight and the skin is closed.
Antithrombosis prophylaxes and a fluid diet are con-
tinued for a minimum of two weeks postoperatively.
Sample size determination
The sample size calculation is based on a superiority de-
sign, assuming that VLRL-RYGB is superior at 1 year
follow-up when compared to standard LRYGB.
H0: mean % EWL at 1 year (standard LRYGB) =mean
% EWL at 1 year (VLRL-RYGB)
H1: mean % EWL at 1 year (standard LRYGB) ≠mean
% EWL at 1 year (VLRL-RYGB)
To be able to reject the null hypothesis that mean
% EWL at 1 year follow-up after standard LRYGB
treatment equals mean % EWL at 1 year follow-up after
VLRL-RYGB, at least 2x210 patients need to be included in
the analysis. (Mean (SD) % EWL is 69.7 % (25.88) after
VLRL-RYGB [19]; and 62.60 (25.88) after standard LRYGB;
power = 80 %, randomization ratio 1:1). Considering a
dropout rate of 5 %, the number of patients that need to be
included is estimated to be 2x210/.95 = 2x221.1 = 444
(rounded up for equal number of patients per group).
The % EWL data of standard LRYGB are obtained
from the meta analysis of Garb et al. [23]. The SD of
VLRL-RYGB which currently is unreported is assumed
to be equal to the SD of standard LRYGB.
Study procedure
Data will be recorded prospectively on designated case
record forms. All data are stored in a database, which is
managed by the principal investigator. All adverse events
will be investigated by a Data Safety Monitoring Board.
Ethics approval
This study will be conducted in accordance to the stan-
dards of Good Clinical Practice, in agreement with the
Declaration of Helsinki (latest amendment), Dutch law in
general and with the W.M.O. in particular.
This trial has been approved by the regional medical
ethical committee; Toetsingscommissie Wetenschappelijk
Onderzoek Rotterdam e.o. (TWOR) at Maasstad Hospital
Rotterdam,The Netherlands.
Discussion
As mentioned in the background section, there are cur-
rently no randomized controlled trials addressing the role
of the common channel in the treatment of the morbidly
obese patient. Savassi et al. [24] addressed this issue by
evaluating the length of the common channel in 100 pa-
tients that underwent LRYGB. They found a negative cor-
relation (though weak) between weight loss and common
limb length. Average common limb length was approxi-
mately 500 cm (range 268–829 cm) in patients receiving a
standardized 110 cm AL and variable BL (average 56 cm,
range 30–105 cm). They concluded that the common chan-
nel length does not play a role in weight loss for proximal
(or short limbs) LRYGB but the variability in jejunoileal
and common channel length should be considered when
making modifications in the AL and BL.
Hernandez-Martinez et al. [25] performed LRYGB with
a fixed common channel length of 230 cm in a series of
565 patients. After measuring the entire small bowel a
length of 230 cm common channel was standardized and
the rest of the small intestine was distributed as 60 % AL
and 40 % BL. They selected 230 cm based on the assump-
tion that this is the normal length of small bowel in adult
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non-obese persons. They found promising results in
achieving long lasting EWL of over 70 % during 8-year
follow-up with few metabolic complications.
In Scopinaro’s biliopancreatic diversion, distal gastrec-
tomy is performed creating a 200–500 ml gastric pouch,
with a 200-cm AL, a common channel of 50 cm, and a BL
of 3–4 metres. Although this approach seems to be super-
ior to RYGB for long term weight loss in super-obese
patients [16, 26–29], high rates of metabolic complications
are a concern [16, 28, 30, 31].
We hypothesize that our proposed VLRL-RYGB will pro-
vide for improved results concerning % EWL with an ac-
ceptable rate of (metabolic) complications in accordance
with the results described by Thurnheer et al. [19] and
Kalafarentzos et al. [17].
Our main point of interest is to determine if the VLRL-
RYGB is a superior alternative to standard LRYGB in
terms of percentage excess weight loss and to put more
focus on the role of the common channel. Therefore we
will perform this randomized controlled trial comparing
both techniques, with % EWL as a primary outcome.
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